The risk or severity of adverse effects can be increased when DEZOCINE is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Etoricoxib is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when pramipexole is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when rasagiline is combined with mirtazapine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when clomipramine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when clomipramine is combined with epoprostenol.


The risk or severity of adverse effects can be increased when LISURIDE is combined with clindamycin.


The risk or severity of adverse effects can be increased when penbutolol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when loxapine is combined with trazodone.


The risk or severity of adverse effects can be increased when biperiden is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when loxapine is combined with pentazocine.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with nifedipine.


The risk or severity of adverse effects can be increased when barnidipine is combined with Rotigotine.


The risk or severity of adverse effects can be increased when benzocaine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when haloperidol is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when haloperidol is combined with chlormezanone.


The risk or severity of adverse effects can be increased when Tolcapone is combined with lisinopril.


The risk or severity of adverse effects can be increased when vigabatrin is combined with doxepin.


The risk or severity of adverse effects can be increased when DESONIDE is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when haloperidol is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when dipyridamole is combined with Apixaban.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Retigabine.


The risk or severity of adverse effects can be increased when trazodone is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when oxazepam is combined with MELPERONE.


The risk or severity of adverse effects can be increased when meperidine is combined with diazepam.


The risk or severity of adverse effects can be increased when Tolcapone is combined with trimipramine.


The risk or severity of adverse effects can be increased when etizolam is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when hexetidine is combined with nicardipine.


The risk or severity of adverse effects can be increased when benazepril is combined with Sacubitril.


The risk or severity of adverse effects can be increased when imipramine is combined with indapamide.


The risk or severity of adverse effects can be increased when ILOPROST is combined with pramipexole.


The risk or severity of adverse effects can be increased when Flibanserin is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when loxapine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when resveratrol is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when temazepam is combined with Melatonin.


The risk or severity of adverse effects can be increased when flurazepam is combined with Tolcapone.


The risk or severity of adverse effects can be increased when flurazepam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with difluprednate.


The risk or severity of adverse effects can be increased when clozapine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when clozapine is combined with zotepine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with methylphenidate.


The risk or severity of adverse effects can be increased when mesoridazine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when METAXALONE is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when zaleplon is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when mesoridazine is combined with triprolidine.


The risk or severity of adverse effects can be increased when ropinirole is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when clorazepate is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when ISOSORBIDE DINITRATE is combined with methyldopa.


The risk or severity of adverse effects can be increased when trandolapril is combined with Bretylium.


The risk or severity of adverse effects can be increased when Etidronic acid is combined with Deferasirox.


The risk or severity of adverse effects can be increased when tioconazole is combined with nitrendipine.


The risk or severity of adverse effects can be increased when thioridazine is combined with bromazepam.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Eprosartan.


The risk or severity of adverse effects can be increased when Clevidipine is combined with pravastatin.


The risk or severity of adverse effects can be increased when ethotoin is combined with Escitalopram.


The risk or severity of adverse effects can be increased when ethotoin is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when thioridazine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with dyclonine.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Bortezomib is combined with clozapine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when chlormezanone is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when labetalol is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when Loxoprofen is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with fludiazepam.


The risk or severity of adverse effects can be increased when quetiapine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when metolazone is combined with acebutolol.


The risk or severity of adverse effects can be increased when pramipexole is combined with Bretylium.


The risk or severity of adverse effects can be increased when butabarbital is combined with sertraline.


The risk or severity of adverse effects can be increased when moclobemide is combined with Vilanterol.


The risk or severity of adverse effects can be increased when moclobemide is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when triazolam is combined with enflurane.


The risk or severity of adverse effects can be increased when proparacaine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when mirtazapine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when methylergonovine is combined with acetazolamide.


The risk or severity of adverse effects can be increased when methylergonovine is combined with propofol.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with ethotoin.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with bumetanide.


The risk or severity of adverse effects can be increased when metaproterenol is combined with dobutamine.


The risk or severity of adverse effects can be increased when Limaprost is combined with Rivaroxaban.


The risk or severity of adverse effects can be increased when propofol is combined with enflurane.


The risk or severity of adverse effects can be increased when triazolam is combined with clonazepam.


The risk or severity of adverse effects can be increased when Desloratadine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when amobarbital is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when clomipramine is combined with losartan.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Flupentixol.


The risk or severity of adverse effects can be increased when Mephobarbital is combined with Retigabine.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when methysergide is combined with Ezetimibe.


The risk or severity of adverse effects can be increased when azelastine is combined with DESONIDE.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when cocaine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when bepridil is combined with Eplerenone.


The risk or severity of adverse effects can be increased when bepridil is combined with methazolamide.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Perospirone.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with Riociguat.


The risk or severity of adverse effects can be increased when bepridil is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with clonidine.


The risk or severity of adverse effects can be increased when HEROIN is combined with clonidine.


The risk or severity of adverse effects can be increased when medrysone is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when ethanol is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Nabilone is combined with sertraline.


The risk or severity of adverse effects can be increased when ethosuximide is combined with promethazine.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when nimesulide is combined with Icatibant.


The risk or severity of adverse effects can be increased when timolol is combined with apraclonidine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when timolol is combined with Telmisartan.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with topiramate.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with quetiapine.


The risk or severity of adverse effects can be increased when oxycodone is combined with fludiazepam.


The risk or severity of adverse effects can be increased when pirenzepine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Difenoxin.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with formestane.


The risk or severity of adverse effects can be increased when amiodarone is combined with nitric oxide.


The risk or severity of adverse effects can be increased when procaine is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when procaine is combined with flunarizine.


The risk or severity of adverse effects can be increased when halothane is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when procaine is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when quetiapine is combined with dibucaine.


The risk or severity of adverse effects can be increased when Normethadone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when MELPERONE is combined with butalbital.


The risk or severity of adverse effects can be increased when betamethasone is combined with galanthamine.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with methyldopa.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when procarbazine is combined with ritodrine.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with tetracaine.


The risk or severity of adverse effects can be increased when norepinephrine is combined with phenylephrine.


The risk or severity of adverse effects can be increased when zaleplon is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when thiamylal is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when amiodarone is combined with triamterene.


The risk or severity of adverse effects can be increased when trazodone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when lidocaine is combined with levodopa.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when equilin is combined with ambenonium.


The risk or severity of adverse effects can be increased when Rufinamide is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when nilvadipine is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when dibucaine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when doxazosin is combined with mecamylamine.


The risk or severity of adverse effects can be increased when carprofen is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when Magnesium trisilicate is combined with misoprostol.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with zonisamide.


The risk or severity of adverse effects can be increased when nilvadipine is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when morniflumate is combined with sulindac.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Olopatadine.


The risk or severity of adverse effects can be increased when glutethimide is combined with Pizotifen.


The risk or severity of adverse effects can be increased when trazodone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when meclizine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when trimeprazine is combined with nefazodone.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Halobetasol.


The risk or severity of adverse effects can be increased when meperidine is combined with sumatriptan.


The risk or severity of adverse effects can be increased when diltiazem is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when meperidine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with alclometasone.


The risk or severity of adverse effects can be increased when bupivacaine is combined with trandolapril.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with formestane.


The risk or severity of adverse effects can be increased when tenoxicam is combined with oxaprozin.


The risk or severity of adverse effects can be increased when Eplerenone is combined with penbutolol.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with imipramine.


The risk or severity of adverse effects can be increased when pimozide is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when irbesartan is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with loratadine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with perphenazine.


The risk or severity of adverse effects can be increased when pimozide is combined with glutethimide.


The risk or severity of adverse effects can be increased when irbesartan is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Alvimopan.


The risk or severity of adverse effects can be increased when meperidine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when floctafenine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when clonazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when clozapine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when promethazine is combined with nefazodone.


The risk or severity of adverse effects can be increased when butalbital is combined with clonidine.


The risk or severity of adverse effects can be increased when Spirapril is combined with alclofenac.


The risk or severity of adverse effects can be increased when sulpiride is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when dicumarol is combined with Deferasirox.


The risk or severity of adverse effects can be increased when pentazocine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Calcium phosphate is combined with Calcifediol.


The risk or severity of adverse effects can be increased when trapidil is combined with Olsalazine.


The risk or severity of adverse effects can be increased when Asenapine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when morphine is combined with Articaine.


The risk or severity of adverse effects can be increased when reserpine is combined with olanzapine.


The risk or severity of adverse effects can be increased when Torasemide is combined with diltiazem.


The risk or severity of adverse effects can be increased when halcinonide is combined with Trovafloxacin.


The risk or severity of adverse effects can be increased when zaleplon is combined with tizanidine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with azelastine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Pentolinium is combined with Mirabegron.


The risk or severity of adverse effects can be increased when midazolam is combined with amisulpride.


The risk or severity of adverse effects can be increased when floctafenine is combined with prednisone.


The risk or severity of adverse effects can be increased when sulconazole is combined with fluvastatin.


The risk or severity of adverse effects can be increased when floctafenine is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when procaine is combined with tiapride.


The risk or severity of adverse effects can be increased when midazolam is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with alclofenac.


The risk or severity of adverse effects can be increased when mepivacaine is combined with butalbital.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with Indacaterol.


The risk or severity of adverse effects can be increased when minoxidil is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Dasatinib is combined with leflunomide.


The risk or severity of adverse effects can be increased when clonidine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when ondansetron is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when floctafenine is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when bromazepam is combined with zonisamide.


The risk or severity of adverse effects can be increased when bromazepam is combined with cocaine.


The risk or severity of adverse effects can be increased when bromazepam is combined with tiagabine.


The risk or severity of adverse effects can be increased when zaleplon is combined with dibucaine.


The risk or severity of adverse effects can be increased when bromazepam is combined with ondansetron.


The risk or severity of adverse effects can be increased when trimipramine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with chloroquine.


The risk or severity of adverse effects can be increased when trimipramine is combined with clomipramine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with sulpiride.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with sulindac.


The risk or severity of adverse effects can be increased when maprotiline is combined with naratriptan.


The risk or severity of adverse effects can be increased when Remoxipride is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when prilocaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with clomipramine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Pizotifen.


The risk or severity of adverse effects can be increased when buspirone is combined with Retigabine.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with loxapine.


The risk or severity of adverse effects can be increased when loxapine is combined with clomipramine.


The risk or severity of adverse effects can be increased when codeine is combined with zopiclone.


The risk or severity of adverse effects can be increased when halothane is combined with indapamide.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Ramelteon.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with primidone.


The risk or severity of adverse effects can be increased when hyoscyamine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with tolazoline.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with baclofen.


The risk or severity of adverse effects can be increased when indapamide is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when diazepam is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when antipyrine is combined with Estrone sulfate.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when nystatin is combined with nilvadipine.


The risk or severity of adverse effects can be increased when Tramadol is combined with mepivacaine.


The risk or severity of adverse effects can be increased when risperidone is combined with enflurane.


The risk or severity of adverse effects can be increased when Tramadol is combined with zaleplon.


The risk or severity of adverse effects can be increased when etizolam is combined with Retigabine.


The risk or severity of adverse effects can be increased when Conivaptan is combined with Flibanserin.


The risk or severity of adverse effects can be increased when Tramadol is combined with Desloratadine.


The risk or severity of adverse effects can be increased when spironolactone is combined with trandolapril.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with benzocaine.


The risk or severity of adverse effects can be increased when ketorolac is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with vigabatrin.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Ramelteon.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Efonidipine.


The risk or severity of adverse effects can be increased when gabapentin is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with fludiazepam.


The risk or severity of adverse effects can be increased when minoxidil is combined with Metipranolol.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with acetylcholine.


The risk or severity of adverse effects can be increased when amitriptyline is combined with ethosuximide.


The risk or severity of adverse effects can be increased when pentazocine is combined with efavirenz.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with methyclothiazide.


The risk or severity of adverse effects can be increased when indomethacin is combined with paramethasone.


The risk or severity of adverse effects can be increased when indomethacin is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when oxymorphone is combined with bupivacaine.


The risk or severity of adverse effects can be increased when pergolide is combined with quinidine.


The risk or severity of adverse effects can be increased when trazodone is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when pergolide is combined with cocaine.


The risk or severity of adverse effects can be increased when trandolapril is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Droxicam is combined with Tiludronic Acid.


The risk or severity of adverse effects can be increased when Almotriptan is combined with procarbazine.


The risk or severity of adverse effects can be increased when Droxicam is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when butamben is combined with Ramelteon.


The risk or severity of adverse effects can be increased when HEROIN is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when malathion is combined with pilocarpine.


The risk or severity of adverse effects can be increased when sulpiride is combined with maprotiline.


The risk or severity of adverse effects can be increased when pergolide is combined with resveratrol.


The risk or severity of adverse effects can be increased when benzocaine is combined with dantrolene.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when itraconazole is combined with Abemaciclib.


The risk or severity of adverse effects can be increased when thioridazine is combined with enflurane.


The risk or severity of adverse effects can be increased when efavirenz is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when meprobamate is combined with Pipamperone.


The risk or severity of adverse effects can be increased when amitriptyline is combined with buspirone.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when oxazepam is combined with Olopatadine.


The risk or severity of adverse effects can be increased when midazolam is combined with maprotiline.


The risk or severity of adverse effects can be increased when Sacubitril is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when midazolam is combined with mesoridazine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when nitrazepam is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when chloroxine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when nitrazepam is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when triflupromazine is combined with paroxetine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with trandolapril.


The risk or severity of adverse effects can be increased when propoxyphene is combined with desipramine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Vecuronium is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when resveratrol is combined with halcinonide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with baclofen.


The risk or severity of adverse effects can be increased when celecoxib is combined with alclofenac.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when nicergoline is combined with arsenic trioxide.


The risk or severity of adverse effects can be increased when cyclophosphamide is combined with atorvastatin.


The risk or severity of adverse effects can be increased when doxazosin is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when venlafaxine is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Atracurium besylate.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when topiramate is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Melatonin.


The risk or severity of adverse effects can be increased when docetaxel is combined with PHENYLACETIC ACID.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with baclofen.


The risk or severity of adverse effects can be increased when Retigabine is combined with paroxetine.


The risk or severity of adverse effects can be increased when nifedipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when morphine is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when methylergonovine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when pimozide is combined with flunarizine.


The risk or severity of adverse effects can be increased when procarbazine is combined with reserpine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with etizolam.


The risk or severity of adverse effects can be increased when ipratropium is combined with ethopropazine.


The risk or severity of adverse effects can be increased when nylidrin is combined with hydroxyamphetamine.


The risk or severity of adverse effects can be increased when Metixene is combined with Mirabegron.


The risk or severity of adverse effects can be increased when chloroquine is combined with diflorasone.


The risk or severity of adverse effects can be increased when cetirizine is combined with flunarizine.


The risk or severity of adverse effects can be increased when morphine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when thiopental is combined with benzyl alcohol.


The risk or severity of adverse effects can be increased when Phenelzine is combined with dipivefrin.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when gemcitabine is combined with bleomycin.


The risk or severity of adverse effects can be increased when halcinonide is combined with metoclopramide.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when ondansetron is combined with baclofen.


The risk or severity of adverse effects can be increased when Fluspirilene is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when LISURIDE is combined with propofol.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when mesalamine is combined with flunisolide.


The risk or severity of adverse effects can be increased when antipyrine is combined with betamethasone.


The risk or severity of adverse effects can be increased when thiamylal is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when butabarbital is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with ritodrine.


The risk or severity of adverse effects can be increased when etodolac is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with halcinonide.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with Mometasone.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with difluprednate.


The risk or severity of adverse effects can be increased when Carbetocin is combined with ramipril.


The risk or severity of adverse effects can be increased when LISURIDE is combined with acetazolamide.


The risk or severity of adverse effects can be increased when duloxetine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with resveratrol.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with lidocaine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with doxepin.


The risk or severity of adverse effects can be increased when mirtazapine is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with venlafaxine.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when celecoxib is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when Tolcapone is combined with nefazodone.


The risk or severity of adverse effects can be increased when Sertaconazole is combined with isradipine.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with ISOSORBIDE DINITRATE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with methadone.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Pizotifen.


The risk or severity of adverse effects can be increased when minoxidil is combined with quetiapine.


The risk or severity of adverse effects can be increased when felodipine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when felodipine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with METAXALONE.


The risk or severity of adverse effects can be increased when diazepam is combined with butalbital.


The risk or severity of adverse effects can be increased when brotizolam is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when nalbuphine is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when ETHACRYNIC ACID is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when fenoprofen is combined with alclometasone.


The risk or severity of adverse effects can be increased when reserpine is combined with haloperidol.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when diflunisal is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when buspirone is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Paliperidone.


The risk or severity of adverse effects can be increased when reserpine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when perphenazine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Remoxipride is combined with topiramate.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Olopatadine.


The risk or severity of adverse effects can be increased when perphenazine is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with formestane.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with Pefloxacin.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with Tapentadol.


The risk or severity of adverse effects can be increased when nicergoline is combined with betamethasone.


The risk or severity of adverse effects can be increased when nicergoline is combined with chloramphenicol.


The risk or severity of adverse effects can be increased when nicergoline is combined with teniposide.


The risk or severity of adverse effects can be increased when nicergoline is combined with lansoprazole.


The risk or severity of adverse effects can be increased when oxazepam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with fexofenadine.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Retigabine.


The risk or severity of adverse effects can be increased when Clobetasone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when amphotericin b is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Butylscopolamine is combined with methadone.


The risk or severity of adverse effects can be increased when oxaprozin is combined with acemetacin.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Tolcapone.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with dantrolene.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with sulpiride.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Ramelteon is combined with levodopa.


The risk or severity of adverse effects can be increased when bumetanide is combined with plicamycin.


The risk or severity of adverse effects can be increased when methysergide is combined with pilocarpine.


The risk or severity of adverse effects can be increased when amobarbital is combined with dibucaine.


The risk or severity of adverse effects can be increased when methysergide is combined with PRIMAQUINE.


The risk or severity of adverse effects can be increased when epoprostenol is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when terconazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when barnidipine is combined with Bretylium.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when pentazocine is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with dipyridamole.


The risk or severity of adverse effects can be increased when pentazocine is combined with triazolam.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with azelastine.


The risk or severity of adverse effects can be increased when duloxetine is combined with Almotriptan.


The risk or severity of adverse effects can be increased when desipramine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when desipramine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when desipramine is combined with moclobemide.


The risk or severity of adverse effects can be increased when Benidipine is combined with fluvastatin.


The risk or severity of adverse effects can be increased when Benidipine is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when pentazocine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when diazepam is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when ibuprofen is combined with formestane.


The risk or severity of adverse effects can be increased when gabapentin is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when dicyclomine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when ticlopidine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with nortriptyline.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with amoxapine.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with theobromine.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Clobetasone is combined with edrophonium.


The risk or severity of adverse effects can be increased when meperidine is combined with cetirizine.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when barnidipine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when clotrimazole is combined with diltiazem.


The risk or severity of adverse effects can be increased when SERATRODAST is combined with dexamethasone.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with tetracaine.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when clozapine is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with pentazocine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with thiamylal.


The risk or severity of adverse effects can be increased when Rufinamide is combined with trazodone.


The risk or severity of adverse effects can be increased when pancuronium is combined with oxymorphone.


The risk or severity of adverse effects can be increased when alprazolam is combined with clomipramine.


The risk or severity of adverse effects can be increased when MEPHENTERMINE is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with halothane.


The risk or severity of adverse effects can be increased when felodipine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with Lumiracoxib.


The risk or severity of adverse effects can be increased when Pipamperone is combined with losartan.


The risk or severity of adverse effects can be increased when rescinnamine is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when HEROIN is combined with trichlormethiazide.


The risk or severity of adverse effects can be increased when loratadine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when diazepam is combined with Milnacipran.


The risk or severity of adverse effects can be increased when levorphanol is combined with phenobarbital.


The risk or severity of adverse effects can be increased when HEROIN is combined with Efonidipine.


The risk or severity of adverse effects can be increased when Voriconazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when captopril is combined with Clevidipine.


The risk or severity of adverse effects can be increased when flurandrenolide is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when thiopental is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when thiopental is combined with Pramocaine.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with Prasugrel.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with quetiapine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with nadolol.


The risk or severity of adverse effects can be increased when Treprostinil is combined with ZILEUTON.


The risk or severity of adverse effects can be increased when chlorzoxazone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when meprobamate is combined with thiopental.


The risk or severity of adverse effects can be increased when DESONIDE is combined with ambenonium.


The risk or severity of adverse effects can be increased when thiothixene is combined with METAXALONE.


The risk or severity of adverse effects can be increased when metoclopramide is combined with Paliperidone.


The risk or severity of adverse effects can be increased when meprobamate is combined with ethosuximide.


The risk or severity of adverse effects can be increased when itraconazole is combined with Amrinone.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with DESONIDE.


The risk or severity of adverse effects can be increased when reserpine is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when haloprogin is combined with bepridil.


The risk or severity of adverse effects can be increased when nabumetone is combined with niflumic acid.


The risk or severity of adverse effects can be increased when clozapine is combined with Paliperidone.


The risk or severity of adverse effects can be increased when imipramine is combined with nilvadipine.


The risk or severity of adverse effects can be increased when Vilazodone is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when midazolam is combined with clidinium.


The risk or severity of adverse effects can be increased when fosinopril is combined with Nebivolol.


The risk or severity of adverse effects can be increased when Vilazodone is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when nimesulide is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when nimesulide is combined with paramethasone.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with nadolol.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when flumethasone is combined with malathion.


The risk or severity of adverse effects can be increased when enflurane is combined with Milnacipran.


The risk or severity of adverse effects can be increased when indinavir is combined with oxycodone.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when cocaine is combined with scopolamine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with Fospropofol.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Retigabine.


The risk or severity of adverse effects can be increased when HYDROCODONE is combined with Torasemide.


The risk or severity of adverse effects can be increased when Carbetocin is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when HEROIN is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when ethyl icosapentate is combined with TROLAMINE SALICYLATE.


The risk or severity of adverse effects can be increased when thiopental is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Carbetocin is combined with phenoxybenzamine.


The risk or severity of adverse effects can be increased when Eplerenone is combined with methazolamide.


The risk or severity of adverse effects can be increased when felodipine is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when cetirizine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when carprofen is combined with paramethasone.


The risk or severity of adverse effects can be increased when Metixene is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when ILOPROST is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when PIPECURONIUM is combined with oxymorphone.


The risk or severity of adverse effects can be increased when lorazepam is combined with dibucaine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when tetracaine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when cilnidipine is combined with metolazone.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Lercanidipine.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with estradiol.


The risk or severity of adverse effects can be increased when thalidomide is combined with prazosin.


The risk or severity of adverse effects can be increased when Voriconazole is combined with manidipine.


The risk or severity of adverse effects can be increased when salicylic acid is combined with epirizole.


The risk or severity of adverse effects can be increased when teniposide is combined with clozapine.


The risk or severity of adverse effects can be increased when procarbazine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when RIMEXOLONE is combined with Demecarium.


The risk or severity of adverse effects can be increased when chlormezanone is combined with baclofen.


The risk or severity of adverse effects can be increased when Olopatadine is combined with epirizole.


The risk or severity of adverse effects can be increased when fenoprofen is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when Butethal is combined with Pramocaine.


The risk or severity of adverse effects can be increased when procyclidine is combined with Methylscopolamine bromide.


The risk or severity of adverse effects can be increased when fenoprofen is combined with fenbufen.


The risk or severity of adverse effects can be increased when Butethal is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with lithium ion.


The risk or severity of adverse effects can be increased when docetaxel is combined with VERTEPORFIN.


The risk or severity of adverse effects can be increased when Perospirone is combined with desipramine.


The risk or severity of adverse effects can be increased when hexetidine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when docetaxel is combined with enoxacin.


The risk or severity of adverse effects can be increased when morniflumate is combined with Lornoxicam.


The risk or severity of adverse effects can be increased when mepivacaine is combined with lithium ion.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when mepivacaine is combined with Butethal.


The risk or severity of adverse effects can be increased when Lurasidone is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when bupivacaine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when haloperidol is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with alclometasone.


The risk or severity of adverse effects can be increased when clozapine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Luliconazole is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with etizolam.


The risk or severity of adverse effects can be increased when metoclopramide is combined with amisulpride.


The risk or severity of adverse effects can be increased when butorphanol is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when oxycodone is combined with Olopatadine.


The risk or severity of adverse effects can be increased when cilazapril is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with Retigabine.


The risk or severity of adverse effects can be increased when cilnidipine is combined with triamterene.


The risk or severity of adverse effects can be increased when butorphanol is combined with topiramate.


The risk or severity of adverse effects can be increased when NAPROXEN is combined with equilin.


The risk or severity of adverse effects can be increased when linezolid is combined with Cyamemazine.


The risk or severity of adverse effects can be increased when pargyline is combined with maprotiline.


The risk or severity of adverse effects can be increased when protriptyline is combined with clidinium.


The risk or severity of adverse effects can be increased when imipramine is combined with nitrendipine.


The risk or severity of adverse effects can be increased when pargyline is combined with Salmeterol.


The risk or severity of adverse effects can be increased when tetracaine is combined with Olopatadine.


The risk or severity of adverse effects can be increased when nicardipine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when irbesartan is combined with floctafenine.


The risk or severity of adverse effects can be increased when meclizine is combined with desipramine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with oxprenolol.


The risk or severity of adverse effects can be increased when sevoflurane is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when alclofenac is combined with Clobetasone.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with tizanidine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with prazepam.


The risk or severity of adverse effects can be increased when carisoprodol is combined with imipramine.


The risk or severity of adverse effects can be increased when bromazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when formestane is combined with rivastigmine.


The risk or severity of adverse effects can be increased when clorazepate is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when Butoconazole is combined with xylometazoline.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when triazolam is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when Vardenafil is combined with alprostadil.


The risk or severity of adverse effects can be increased when formestane is combined with physostigmine.


The risk or severity of adverse effects can be increased when nabumetone is combined with mycophenolate mofetil.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with PIRFENIDONE.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with zaleplon.


The risk or severity of adverse effects can be increased when lorazepam is combined with amoxapine.


The risk or severity of adverse effects can be increased when tetracaine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Clobetasone.


The risk or severity of adverse effects can be increased when trandolapril is combined with Clevidipine.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when apomorphine is combined with LEVOSIMENDAN.


The risk or severity of adverse effects can be increased when METHSUXIMIDE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when Oxetacaine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when Naftifine is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with dyclonine.


The risk or severity of adverse effects can be increased when bromazepam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when Masoprocol is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when imipramine is combined with moclobemide.


The risk or severity of adverse effects can be increased when secobarbital is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when methysergide is combined with Rilpivirine.


The risk or severity of adverse effects can be increased when methysergide is combined with Crizotinib.


The risk or severity of adverse effects can be increased when clozapine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when norepinephrine is combined with Ephedrine.


The risk or severity of adverse effects can be increased when Pirlindole is combined with OLODATEROL.


The risk or severity of adverse effects can be increased when norepinephrine is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when Micafungin is combined with nimodipine.


The risk or severity of adverse effects can be increased when apraclonidine is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when zotepine is combined with loratadine.


The risk or severity of adverse effects can be increased when reserpine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when zotepine is combined with imipramine.


The risk or severity of adverse effects can be increased when Gliquidone is combined with Carbocisteine.


The risk or severity of adverse effects can be increased when docetaxel is combined with TRIPTORELIN.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Pramocaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when secobarbital is combined with clidinium.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with Iloperidone.


The risk or severity of adverse effects can be increased when prazosin is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when zaleplon is combined with Tolcapone.


The risk or severity of adverse effects can be increased when butalbital is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when zaleplon is combined with amitriptyline.


The risk or severity of adverse effects can be increased when methylergonovine is combined with nevirapine.


The risk or severity of adverse effects can be increased when meperidine is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when prazepam is combined with Flibanserin.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with epirizole.


The risk or severity of adverse effects can be increased when loxapine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when methysergide is combined with resveratrol.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with nicotinamide.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when proparacaine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when tolterodine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when proparacaine is combined with mepivacaine.


The risk or severity of adverse effects can be increased when flurazepam is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when nimodipine is combined with nifedipine.


The risk or severity of adverse effects can be increased when docetaxel is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Conivaptan is combined with doxazosin.


The risk or severity of adverse effects can be increased when Conivaptan is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Conivaptan is combined with labetalol.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with hydromorphone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with scopolamine.


The risk or severity of adverse effects can be increased when fosinopril is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when naratriptan is combined with Ziprasidone.


The risk or severity of adverse effects can be increased when Remoxipride is combined with doxepin.


The risk or severity of adverse effects can be increased when Nabilone is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Miltefosine is combined with bepridil.


The risk or severity of adverse effects can be increased when bromocriptine is combined with tetracycline.


The risk or severity of adverse effects can be increased when zotepine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when bromocriptine is combined with isoflurane.


The risk or severity of adverse effects can be increased when fenbufen is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when fenbufen is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when bromocriptine is combined with tretinoin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with clonazepam.


The risk or severity of adverse effects can be increased when bupivacaine is combined with promethazine.


The risk or severity of adverse effects can be increased when prazepam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with lithium ion.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Melatonin.


The risk or severity of adverse effects can be increased when diflorasone is combined with Echothiophate.


The risk or severity of adverse effects can be increased when tolmetin is combined with salicylamide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with ketamine.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with losartan.


The risk or severity of adverse effects can be increased when olanzapine is combined with Halazepam.


The risk or severity of adverse effects can be increased when methysergide is combined with cilostazol.


The risk or severity of adverse effects can be increased when carboplatin is combined with clozapine.


The risk or severity of adverse effects can be increased when losartan is combined with fosinopril.


The risk or severity of adverse effects can be increased when olanzapine is combined with proparacaine.


The risk or severity of adverse effects can be increased when methysergide is combined with itraconazole.


The risk or severity of adverse effects can be increased when codeine is combined with Perospirone.


The risk or severity of adverse effects can be increased when etizolam is combined with Pipamperone.


The risk or severity of adverse effects can be increased when carisoprodol is combined with meclizine.


The risk or severity of adverse effects can be increased when lidocaine is combined with triprolidine.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with galanthamine.


The risk or severity of adverse effects can be increased when Anidulafungin is combined with Pinaverium.


The risk or severity of adverse effects can be increased when lidocaine is combined with methocarbamol.


The risk or severity of adverse effects can be increased when chloroquine is combined with salicylamide.


The risk or severity of adverse effects can be increased when terconazole is combined with nimesulide.


The risk or severity of adverse effects can be increased when levorphanol is combined with methazolamide.


The risk or severity of adverse effects can be increased when levorphanol is combined with Eplerenone.


The risk or severity of adverse effects can be increased when tacrolimus is combined with Nelarabine.


The risk or severity of adverse effects can be increased when aspirin is combined with medrysone.


The risk or severity of adverse effects can be increased when salicylamide is combined with amcinonide.


The risk or severity of adverse effects can be increased when Miltefosine is combined with nimesulide.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when Eletriptan is combined with Cariprazine.


The risk or severity of adverse effects can be increased when salicylamide is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when flurazepam is combined with diazepam.


The risk or severity of adverse effects can be increased when oxymetazoline is combined with tetrahydrozoline.


The risk or severity of adverse effects can be increased when amiodarone is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Halazepam is combined with halothane.


The risk or severity of adverse effects can be increased when amiodarone is combined with Telmisartan.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when cabergoline is combined with alprazolam.


The risk or severity of adverse effects can be increased when moclobemide is combined with oxycodone.


The risk or severity of adverse effects can be increased when ATROPINE is combined with propoxyphene.


The risk or severity of adverse effects can be increased when butorphanol is combined with Naloxegol.


The risk or severity of adverse effects can be increased when moclobemide is combined with buspirone.


The risk or severity of adverse effects can be increased when Halazepam is combined with thiamylal.


The risk or severity of adverse effects can be increased when benazepril is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when haloperidol is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with meclizine.


The risk or severity of adverse effects can be increased when hydromorphone is combined with furosemide.


The risk or severity of adverse effects can be increased when Pentyl nitrite is combined with Clevidipine.


The risk or severity of adverse effects can be increased when thiamylal is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when BALSALAZIDE is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when losartan is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when Paliperidone is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Talniflumate is combined with salicylic acid.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with nadolol.


The risk or severity of adverse effects can be increased when diazepam is combined with atorvastatin.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with desipramine.


The risk or severity of adverse effects can be increased when Halazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when tiaprofenic acid is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when ketamine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Talniflumate is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when nitrazepam is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with furosemide.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with tizanidine.


The risk or severity of adverse effects can be increased when clotrimazole is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when cabergoline is combined with haloperidol.


The risk or severity of adverse effects can be increased when venlafaxine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when codeine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when clorazepate is combined with quazepam.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when hydrochlorothiazide is combined with Riociguat.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with flunarizine.


The risk or severity of adverse effects can be increased when tioconazole is combined with Pinaverium.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Riociguat.


The risk or severity of adverse effects can be increased when ISOSORBIDE MONONITRATE is combined with NITROUS ACID.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with formestane.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Elbasvir.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when halothane is combined with brotizolam.


The risk or severity of adverse effects can be increased when fenbufen is combined with Halobetasol.


The risk or severity of adverse effects can be increased when fenbufen is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when cilazapril is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when clotrimazole is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when dyclonine is combined with propoxyphene.


The risk or severity of adverse effects can be increased when Masoprocol is combined with difluprednate.


The risk or severity of adverse effects can be increased when Masoprocol is combined with halcinonide.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with doxepin.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when duloxetine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when carisoprodol is combined with promethazine.


The risk or severity of adverse effects can be increased when carisoprodol is combined with clonazepam.


The risk or severity of adverse effects can be increased when Butethal is combined with protriptyline.


The risk or severity of adverse effects can be increased when Normethadone is combined with promethazine.


The risk or severity of adverse effects can be increased when Normethadone is combined with clonazepam.


The risk or severity of adverse effects can be increased when Butethal is combined with cetirizine.


The risk or severity of adverse effects can be increased when barnidipine is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when bromocriptine is combined with tioconazole.


The risk or severity of adverse effects can be increased when metoclopramide is combined with tiapride.


The risk or severity of adverse effects can be increased when Tolcapone is combined with trandolapril.


The risk or severity of adverse effects can be increased when amoxapine is combined with Gabapentin enacarbil.


The risk or severity of adverse effects can be increased when triamterene is combined with methazolamide.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Torasemide.


The risk or severity of adverse effects can be increased when ibuprofen is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when pramipexole is combined with losartan.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when meclizine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when lidocaine is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when pancuronium is combined with hydromorphone.


The risk or severity of adverse effects can be increased when acebutolol is combined with Ephedrine.


The risk or severity of adverse effects can be increased when diflorasone is combined with cinoxacin.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Difenoxin.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when risperidone is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Pramocaine.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when thiamylal is combined with Etidocaine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with loteprednol.


The risk or severity of adverse effects can be increased when zopiclone is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Conivaptan is combined with oxprenolol.


The risk or severity of adverse effects can be increased when propofol is combined with Perospirone.


The risk or severity of adverse effects can be increased when METAXALONE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with diclofenac.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with efavirenz.


The risk or severity of adverse effects can be increased when tioconazole is combined with bepridil.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with lithium ion.


The risk or severity of adverse effects can be increased when fludiazepam is combined with tetracaine.


The risk or severity of adverse effects can be increased when xylometazoline is combined with lovastatin.


The risk or severity of adverse effects can be increased when quinapril is combined with BALSALAZIDE.


The risk or severity of adverse effects can be increased when isoflurane is combined with acebutolol.


The risk or severity of adverse effects can be increased when quinapril is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when glutethimide is combined with maprotiline.


The risk or severity of adverse effects can be increased when azelastine is combined with aspirin.


The risk or severity of adverse effects can be increased when alclofenac is combined with loteprednol.


The risk or severity of adverse effects can be increased when prazepam is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when labetalol is combined with clenbuterol.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with Butethal.


The risk or severity of adverse effects can be increased when estazolam is combined with desipramine.


The risk or severity of adverse effects can be increased when amobarbital is combined with Fospropofol.


The risk or severity of adverse effects can be increased when betaxolol is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when estazolam is combined with thiamylal.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Propacetamol.


The risk or severity of adverse effects can be increased when enalapril is combined with Clevidipine.


The risk or severity of adverse effects can be increased when estazolam is combined with halothane.


The risk or severity of adverse effects can be increased when Icatibant is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when triazolam is combined with halothane.


The risk or severity of adverse effects can be increased when Icatibant is combined with paramethasone.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Agomelatine.


The risk or severity of adverse effects can be increased when glutethimide is combined with vigabatrin.


The risk or severity of adverse effects can be increased when oxycodone is combined with halothane.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with mepivacaine.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with propoxyphene.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with MEDROGESTONE.


The risk or severity of adverse effects can be increased when PREDNICARBATE is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when benzyl alcohol is combined with meclizine.


The risk or severity of adverse effects can be increased when butalbital is combined with methocarbamol.


The risk or severity of adverse effects can be increased when secobarbital is combined with oxymorphone.


The risk or severity of adverse effects can be increased when clorazepate is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with chloroquine.


The risk or severity of adverse effects can be increased when amobarbital is combined with mesoridazine.


The risk or severity of adverse effects can be increased when fluoxetine is combined with procarbazine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with sulindac.


The risk or severity of adverse effects can be increased when barnidipine is combined with rasagiline.


The risk or severity of adverse effects can be increased when phenobarbital is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when risperidone is combined with Remoxipride.


The risk or severity of adverse effects can be increased when Metixene is combined with propoxyphene.


The risk or severity of adverse effects can be increased when risperidone is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when Normethadone is combined with acetazolamide.


The risk or severity of adverse effects can be increased when TAMSULOSIN is combined with enalapril.


The risk or severity of adverse effects can be increased when Amrinone is combined with pravastatin.


The risk or severity of adverse effects can be increased when halothane is combined with terazosin.


The risk or severity of adverse effects can be increased when halothane is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Vilazodone is combined with risperidone.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with epirizole.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Iloperidone.


The risk or severity of adverse effects can be increased when ergocalciferol is combined with dihydrotachysterol.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with ibuprofen.


The risk or severity of adverse effects can be increased when Toloxatone is combined with bupropion.


The risk or severity of adverse effects can be increased when Efonidipine is combined with Canagliflozin.


The risk or severity of adverse effects can be increased when enalapril is combined with salicylamide.


The risk or severity of adverse effects can be increased when isoflurane is combined with Eprosartan.


The risk or severity of adverse effects can be increased when SUFENTANIL is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with amitriptyline.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when betaxolol is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with carisoprodol.


The risk or severity of adverse effects can be increased when mesoridazine is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when cerulenin is combined with eperisone.


The risk or severity of adverse effects can be increased when THYMOL is combined with nilvadipine.


The risk or severity of adverse effects can be increased when moclobemide is combined with mirtazapine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with amitriptyline.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Tolcapone.


The risk or severity of adverse effects can be increased when indapamide is combined with Eprosartan.


The risk or severity of adverse effects can be increased when gemcitabine is combined with leflunomide.


The risk or severity of adverse effects can be increased when D-mannitol is combined with quetiapine.


The risk or severity of adverse effects can be increased when apomorphine is combined with tolazoline.


The risk or severity of adverse effects can be increased when apomorphine is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Rotigotine is combined with propranolol.


The risk or severity of adverse effects can be increased when propranolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with tizanidine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with felodipine.


The risk or severity of adverse effects can be increased when apomorphine is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when pimozide is combined with Perospirone.


The risk or severity of adverse effects can be increased when antipyrine is combined with budesonide.


The risk or severity of adverse effects can be increased when cabergoline is combined with clomipramine.


The risk or severity of adverse effects can be increased when triazolam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when irbesartan is combined with Choline magnesium trisalicylate.


The risk or severity of adverse effects can be increased when cabergoline is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Flibanserin.


The risk or severity of adverse effects can be increased when zopiclone is combined with ketamine.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when quinapril is combined with carprofen.


The risk or severity of adverse effects can be increased when meperidine is combined with DESFLURANE.


The risk or severity of adverse effects can be increased when ramipril is combined with Metipranolol.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with moclobemide.


The risk or severity of adverse effects can be increased when calcium lactate is combined with Calcifediol.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with ethotoin.


The risk or severity of adverse effects can be increased when oxymorphone is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when Flupentixol is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when propofol is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when indomethacin is combined with loteprednol.


The risk or severity of adverse effects can be increased when isradipine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when quetiapine is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when amobarbital is combined with thiamylal.


The risk or severity of adverse effects can be increased when meperidine is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when alprazolam is combined with citalopram.


The risk or severity of adverse effects can be increased when amobarbital is combined with halothane.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with bumetanide.


The risk or severity of adverse effects can be increased when Sacubitril is combined with Icatibant.


The risk or severity of adverse effects can be increased when CYPROHEPTADINE is combined with Retigabine.


The risk or severity of adverse effects can be increased when pimozide is combined with oxymorphone.


The risk or severity of adverse effects can be increased when sevoflurane is combined with baclofen.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with clidinium.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when pimozide is combined with zopiclone.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Panobinostat.


The risk or severity of adverse effects can be increased when amobarbital is combined with Dexbrompheniramine.


The risk or severity of adverse effects can be increased when bromazepam is combined with halothane.


The risk or severity of adverse effects can be increased when Toloxatone is combined with reserpine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with secobarbital.


The risk or severity of adverse effects can be increased when bromazepam is combined with thiamylal.


The risk or severity of adverse effects can be increased when amobarbital is combined with Remoxipride.


The risk or severity of adverse effects can be increased when bromazepam is combined with desipramine.


The risk or severity of adverse effects can be increased when Telmisartan is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Iloperidone.